Natriuretic peptides in the diagnosis and management of acute heart failure.

Full Abstract

The emergence of BNP or NT-proBNP testing has improved the management of acutely decompensated heart failure patients significantly by aiding in early recognition, prognostication, and treatment. Furthermore, their logical application may not only reduce healthcare costs but also potentially reduce adverse clinical outcomes. This article reviews the understanding of utilizing natriuretic peptide testing to correctly diagnose and manage acute heart failure.

Author information

Author/s: Mohammed, Asim A (AA); Januzzi, James L (JL);

Affiliation: Harvard Medical School, Boston, MA, USA.

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: Heart failure clinics (Heart Fail Clin), published in United States. (Language: eng)

Reference: 2009-Oct; vol 5 (issue 4) : pp 489-500

Dates: Created 2009/07/27; Completed 2009/10/28;

PMID: 19631174, status: MEDLINE (last retrieval date: 10/28/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.